ATAI Life Sciences Files 8-K Report
Ticker: ATAI · Form: 8-K · Filed: Mar 20, 2025 · CIK: 1840904
| Field | Detail |
|---|---|
| Company | Atai Life Sciences N.V. (ATAI) |
| Form Type | 8-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, sec-filing
TL;DR
ATAI Life Sciences filed an 8-K on 3/20/25 confirming its Dutch incorporation and German HQ.
AI Summary
On March 20, 2025, ATAI Life Sciences N.V. filed an 8-K report. The filing indicates that the company is incorporated in The Netherlands and its principal executive offices are located in Berlin, Germany. This report is a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This filing provides official confirmation of ATAI Life Sciences N.V.'s corporate structure and reporting status with the SEC.
Risk Assessment
Risk Level: low — This is a routine corporate filing with no new material financial or operational information disclosed.
Key Players & Entities
- ATAI Life Sciences N.V. (company) — Registrant
- The Netherlands (jurisdiction) — State of incorporation
- Berlin, Germany (location) — Principal executive offices
- March 20, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for ATAI Life Sciences N.V.?
The primary purpose is to serve as a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating the date of the report and confirming corporate details.
When was this 8-K report filed?
The report was filed as of March 20, 2025.
Where is ATAI Life Sciences N.V. incorporated?
ATAI Life Sciences N.V. is incorporated in The Netherlands.
What is the address of ATAI Life Sciences N.V.'s principal executive offices?
The principal executive offices are located at Wallstraße 16, 10179 Berlin, Germany.
Does this filing disclose any new financial results or material business events?
Based on the provided text, this filing appears to be a routine corporate disclosure and does not explicitly mention new financial results or material business events.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 20, 2025 regarding ATAI Life Sciences N.V. (ATAI).